Business description: TearLab Corporation

Sales by Activity: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
Diagnostic Kits / Equipment | 22.66M |
Geographical breakdown of sales: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 21.29M |
Rest of the World | 1.37M |
Executive Committee: TearLab Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Szaronos
CEO | Chief Executive Officer | - | 01/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 17/07/2009 | |
John Lund
DFI | Director of Finance/CFO | 60 | 01/07/2022 |
Steve Zmina
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2006 |
Michael Berg
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Composition of the Board of Directors: TearLab Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Uri Geiger
BRD | Director/Board Member | 58 | 09/07/2020 |
James V. Mazzo
CHM | Chairman | 68 | 09/12/2021 |
| Director/Board Member | 78 | 01/09/2004 | |
Dolev Rafaeli
BRD | Director/Board Member | 62 | - |
Barak Azmon
BRD | Director/Board Member | - | - |
David Carter
BRD | Director/Board Member | - | - |
Douglas Strang
BRD | Director/Board Member | - | - |
Company details: TearLab Corporation

Glasses, Spectacles & Contact Lenses
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.52% | +4.85% | -11.20% | +14.59% | 184B | ||
| +2.64% | +4.44% | +9.76% | +37.33% | 118B | ||
| +4.66% | -0.36% | -14.84% | +9.63% | 111B | ||
| +1.41% | +6.80% | -41.04% | +6.45% | 94.58B | ||
| +1.18% | +1.41% | -1.84% | +74.13% | 63.13B | ||
| -5.48% | -5.08% | -1.24% | +63.86% | 55.66B | ||
| +0.59% | +1.27% | +12.18% | -22.28% | 53.9B | ||
| +20.36% | +16.41% | -8.18% | +58.26% | 43.42B | ||
| +2.23% | +4.24% | +2.48% | -8.32% | 34.68B | ||
| Average | +3.43% | +0.06% | -5.99% | +25.96% | 84.27B | |
| Weighted average by Cap. | +3.10% | +0.24% | -8.22% | +23.80% |

















